Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
McKesson
Express Scripts
Boehringer Ingelheim

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for DCC-2618


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug DCC-2618?

DCC-2618 is an investigational drug.

There have been 29 clinical trials for DCC-2618. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2010.

The most common disease conditions in clinical trials are Gastrointestinal Stromal Tumors, Neoplasms, and Diabetes Mellitus. The leading clinical trial sponsors are Deciphera Pharmaceuticals LLC, National Heart, Lung, and Blood Institute (NHLBI), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Recent Clinical Trials for DCC-2618
TitleSponsorPhase
Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)Deciphera Pharmaceuticals LLCPhase 1/Phase 2
A Safety, Tolerability and PK Study of DCC-3116 in Patients With RAS or RAF Mutant Advanced or Metastatic Solid Tumors.Deciphera Pharmaceuticals LLCPhase 1
A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With ImatinibZai Lab (Shanghai) Co., Ltd.Phase 2

See all DCC-2618 clinical trials

Clinical Trial Summary for DCC-2618

Top disease conditions for DCC-2618
Top clinical trial sponsors for DCC-2618

See all DCC-2618 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
McKesson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.